Quitting smoking, losing weight, and renouncing alcohol and cocaine may lead you to the risk of depression and even the chances of suicide. Now, it’s so very evident that the pills like Chantix, Rimonobant, and Taranabant are not free of offshoots as they lump pleasure centers in the brain that offer the feel-good response from smoking or eating. Chantix, a hyped quit-smoking pill from Pfizer Inc. has been allied to several reports of suicides or suicidal behaviors. In February, the FDA said a linkage between Chantix and psychiatric problems appear ‘gradually more liable.’ Though it is believed that risks about Chantix will prove manageable because they mark nicotine pleasure switches and the side effects vary from person to person. Nicotine extraction and even quitting smoking can cause temper swings and depression. The risk-benefit quotient is seriously supporting use of the medication as the alternative, smoking, is comparatively highly risky. Rimonobant and Taranabant, the anti-obesity pills, are also related to depression and suicides. Doctors haven’t remained to be so very optimistic about these professed ”super pills”. In a new research last month, 43 percent of people using Rimonabant developed psychiatric troubles against 28 percent of those on dummy pills. One suicide and one attempt were reported in the studies. Even if the patient goes forward with the lowest doses in the case of Taranabant, the side-effects can’t be annulled. So, there are slim chances of any real benefits coming out of these above mentioned pills taking care of obesity and smoking. Well has Dr. James Stein, a University of Wisconsin-Madison cardiologist, put it,” The door is closing” Source: Kpic